• Calithera Earns $12M Incyte Milestone contractpharma
    March 29, 2017
    Calithera Biosciences has achieved pharmacokinetic and pharmacodynamic goals for CB-1158 under its agreement with Incyte Corp., triggering a $12 million payment from Incyte.
PharmaSources Customer Service